Search
Powered By HealthLine
Health Tools
 Children's Allergies Q&A
 Childhood Asthma Guide
 Childhood Asthma Prognosis
 Identifying Depression in Children
 Treating Childhood Depression
Featured Conditions
 Cold & Flu
 Allergy
 Asthma
 Depression
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Stopping Breast Milk Transmission of HIV

Ivanhoe Newswire


Related Encyclopedia
 border=
Acne
Alagille Syndrome
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
Coming Around: Coma Breakthroughs
Baby Steps: Fertility Findings
Saving Infants from Killer Bacteria: NEC
Tumor Detecting App: Medicine's Next Big Thing?
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Dental Cavities
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Adderal XR
Concerta
Detrol LA
More...

Related News Articles
 border=
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
Young Women Who Drink and Drive at Higher Risk of Fatal Accident
1 in 5 Pharmacies Hinders Teens' Access to 'Morning-After' Pill: Study
More...

(Ivanhoe Newswire) -- Breastfeeding is an important source of nutrients for babies, but it can also spread the human immunodeficiency virus type 1 (HIV-1). Now a drug may offer protection.

In sub-Saharan Africa, breastfeeding is critical for infant survival. However, 16 percent of untreated infants breast-fed after their first birthdays are infected with HIV-1. Studying mothers in Blantyre, Malawi, researchers found using the antiretroviral drugs nevirapine (Viramune) or a combination of nevirapine and zidovudine (INN) for the first 14 weeks of life significantly reduced the spread of HIV-1 infection after birth in nine-month-old infants.

Text Continues Below



Compared with the control, those taking the drugs had significantly lower rates of HIV-1 infection from the age of six weeks to 18 months. At nine months, 5.2 percent of the infants given nevirapine and 6.4 percent of those given the dual-drug combination were infected, compared to 10.6 percent of infants in the control group.

There were no significant differences in efficacy between the two extended-prophylaxis groups, study authors wrote. However, serious adverse events (primarily neutropenia) that were possibly related to a study drug were more frequent in the extended-dual-prophylaxis group.

The authors say more research needs to be done before establishing whether babies of HIV-1-infected mothers should receive antiretroviral prophylaxis while they are being breast-fed.

SOURCE: The New England Journal of Medicine, 2008;359:119-29

Studies show up to 20 percent of a childs IQ is influenced by prenatal and postnatal experience. Learn what you and your baby need before and after birth with these 15 compelling news reports produced by the leading medical news reporting team in the country. Click here to order the DVD, Your Baby: What Every Pregnant Woman Should Know.

 

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 7/11/2008

Related Links
 border=
From Healthscout's partner site on adhd, ADHDCentral.com
Find tips for parenting children with ADHD
Learn how to cope with Adult ADHD
What treatment options are available for ADHD?





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire